Literature DB >> 19760621

Cranioectodermal dysplasia: a probable ciliopathy.

Anastasia E Konstantinidou1, Helen Fryssira, Stavros Sifakis, Charalampos Karadimas, Petros Kaminopetros, Georgios Agrogiannis, Stylianos Velonis, Peter G J Nikkels, Efstratios Patsouris.   

Abstract

Cranioectodermal dysplasia (CED), also known as Sensenbrenner syndrome, is a rare autosomal recessive genetic disorder characterized by typical craniofacial, skeletal and ectodermal defects, and tubulointerstitial nephritis leading to early end-stage renal failure. We report on a new familial case of a 9-year-old patient and two fetuses of 23 and 19 weeks of gestation respectively. Hypohidrosis was an additional ectodermal finding is the patient with CED. Postmortem findings in the two fetuses included acromesomelic shortening, craniofacial characteristics with absence of craniosynostosis, small kidneys with tubular and glomerular microscopic cysts, persistent ductal plate with portal fibrosis in the liver, small adrenals and roughly unremarkable histopathology of the physeal growth plate. Posterior fossa anomalies were additional findings in this patient and included an enlarged cisterna magna and a posterior fossa cyst. The above findings, in association with renal cysts, persistent ductal plate and portal fibrosis, introduce CED, a nonlethal genetic skeletal disorder of yet unknown molecular origin, as a possible member of the expanding group of ciliopathies.

Entities:  

Mesh:

Year:  2009        PMID: 19760621     DOI: 10.1002/ajmg.a.33013

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  12 in total

Review 1.  Craniofacial ciliopathies: A new classification for craniofacial disorders.

Authors:  Samantha A Brugmann; Dwight R Cordero; Jill A Helms
Journal:  Am J Med Genet A       Date:  2010-12       Impact factor: 2.802

2.  Cranioectodermal Dysplasia, Sensenbrenner syndrome, is a ciliopathy caused by mutations in the IFT122 gene.

Authors:  Joanna Walczak-Sztulpa; Jonathan Eggenschwiler; Daniel Osborn; Desmond A Brown; Francesco Emma; Claus Klingenberg; Raoul C Hennekam; Giuliano Torre; Masoud Garshasbi; Andreas Tzschach; Malgorzata Szczepanska; Marian Krawczynski; Jacek Zachwieja; Danuta Zwolinska; Philip L Beales; Hans-Hilger Ropers; Anna Latos-Bielenska; Andreas W Kuss
Journal:  Am J Hum Genet       Date:  2010-05-20       Impact factor: 11.025

Review 3.  The emerging face of primary cilia.

Authors:  Norann A Zaghloul; Samantha A Brugmann
Journal:  Genesis       Date:  2011-04-01       Impact factor: 2.487

Review 4.  Ciliopathies: the central role of cilia in a spectrum of pediatric disorders.

Authors:  Thomas W Ferkol; Margaret W Leigh
Journal:  J Pediatr       Date:  2011-12-16       Impact factor: 4.406

5.  Non-syndromic occurrence of multiple dental and skeletal anomalies: a rare case report and brief literature review.

Authors:  Santosh Patil; Nidhi Yadav; Prashant Patil
Journal:  J Clin Diagn Res       Date:  2014-07-20

6.  WDR35 mutation in siblings with Sensenbrenner syndrome: a ciliopathy with variable phenotype.

Authors:  Carlos A Bacino; Shweta U Dhar; Nicola Brunetti-Pierri; Brendan Lee; Penelope E Bonnen
Journal:  Am J Med Genet A       Date:  2012-09-17       Impact factor: 2.802

Review 7.  Cilia/Ift protein and motor -related bone diseases and mouse models.

Authors:  Xue Yuan; Shuying Yang
Journal:  Front Biosci (Landmark Ed)       Date:  2015-01-01

Review 8.  Current insights into renal ciliopathies: what can genetics teach us?

Authors:  Heleen H Arts; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-07-25       Impact factor: 3.714

Review 9.  Educational paper: ciliopathies.

Authors:  Carsten Bergmann
Journal:  Eur J Pediatr       Date:  2011-09-07       Impact factor: 3.183

10.  Novel IFT122 mutation associated with impaired ciliogenesis and cranioectodermal dysplasia.

Authors:  Anas M Alazami; Mohammed Zain Seidahmed; Fatema Alzahrani; Adam O Mohammed; Fowzan S Alkuraya
Journal:  Mol Genet Genomic Med       Date:  2013-12-10       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.